Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

Overview

After Axillary lymphadenectomy for breast cancer there are not few patients showed seroma formation and it can not be ignored.Investigators aimed to study two new methods of application of Microfibrillar Collagen Hemostat Flour and OK-432 to reduce seroma formation and to verify the efficacy and safety of these two applications.Try to prove them as beneficial supplements for axillary lymphadenectomy of breast cancer.

Full Title of Study: “Contrast The Role of Microfibrillar Collagen Hemostat Flour(Avitene) And OK-432 (Sapylin)in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Care Provider)
  • Study Primary Completion Date: November 2014

Detailed Description

A prospective,randomized analysis of breast-conserving surgery or mastectomy plus axillary lymphadenectomy for those patients with sentinel node positive using Microfibrillar Collagen Hemostat Flour 、 OK-432 or using nothing in equal probability.Up to 12 months,a total of 180 will be recruited in plan.During the operation and after the axillary lymphadenectomy,according the arms,Investigators put Microfibrillar Collagen Hemostat Flour(avitene)、 OK-432(Sapylin) or nothing into patients axillary wounds。And Investigators will the statistical significance of these three arms that the postoperative drainage magnitude and duration.Also the complications associated with axillary lymphadenectomy will be studied.

Interventions

  • Drug: Avitene
  • Drug: Sapylin
  • Behavioral: axillary drainage
  • Other: reexamine

Arms, Groups and Cohorts

  • Experimental: Avitene,Drainaging,reexamine
  • Experimental: Sapylin,Drainaging,reexamine
  • Active Comparator: Drainaging,reexamine

Clinical Trial Outcome Measures

Primary Measures

  • postoperative drainage magnitude
    • Time Frame: up to 1 year

Secondary Measures

  • Duration of the drainage
    • Time Frame: up to 1 year

Participating in This Clinical Trial

Inclusion Criteria

1. Patients volunteered for the study and signed informed consent; 2. Preoperative biopsy or intraoperative sentinel lymph node biopsy confirmed axillary lymph node metastasis and need axillary lymphadenectomy 3. No penicillin allergy 4. No blood system diseases 5. No rheumatic heart disease 6. No history or family history of asthma 7. No history of axillary surgery Exclusion Criteria:

1. A history of severe hypertension 2. A history of diabetes 3. Undergoing anticoagulant therapy or anticoagulant therapy drug withdrawal less than a year 4. BMI>30 5. Can not accept telephone follow-up or can not go to the hospital for subsequent inspection treatment

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
  • Collaborator
    • Guangzhou Women and Children’s Medical Center
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jia Weijuan, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University – Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
  • Overall Official(s)
    • Jia Wei juan, Principal Investigator, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
  • Overall Contact(s)
    • Jia Wei juan, +86-20-34071157, 13560328074@163.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.